Geizhals S, Lipner SR: Review of onychocryptosis: epidemiology, pathogenesis, risk factors, diagnosis and treatment. Dermatol Online J 25: 13030/qt9985w2n0, 2019.
Arica IE, Bostanci S, Kocyigit P, et al: Clinical and sociodemographic characteristics of patients with ingrown nails. JAPMA 109: 201, 2019.
Arica IE, Bostanci S, Koçyigit P, et al: Clinical and sociodemographic characteristics of ingrown nails in children. JAPMA 109: 272, 2019.
Mayeaux E Jr, Carter C, Murphy TE: Ingrown toenail management. Am Fam Physician 100: 158, 2019.
Ma H: Six steps to standardize the surgical approach for ingrown toenail. An Bras Dermatol 96: 47, 2021.
Heifetz CJ: Ingrown toe-nail: a clinical study. Am J Surg 38: 298, 1937.
Khunger N, Kandhari R: Ingrown toenails. Indian J Dermatol Venereol Leprol 78: 279, 2012.
Levy LA: Prevalence of chronic podiatric conditions in the US: National Health Survey 1990. JAPMA 82: 221, 1992.
Kimata Y, Uetake M, Tsukada S, et al: Follow-up study of patients treated for ingrown nails with the nail matrix phenolization method. Plast Reconstr Surg 95: 719, 1995.
James CW, McNelis KC, Cohen DM, et al: Recurrent ingrown toenails secondary to indinavir/ritonavir combination therapy. Ann Pharmacother 35: 881, 2001.
Olujohungbe A, Cox J, Hammon M, et al: Ingrowing toenails and cyclosporin. Lancet 342: 1111, 1993.
Bostanci S, Ekmekci P, Akyol A, et al: Pincer nail deformity: inherited and caused by a beta‐blocker. Int J Dermatol 43: 316, 2004.
Langford D, Burke C, Robertson K: Risk factors in onychocryptosis. Br J Surg 76: 45, 1989.
Haider A, Solish N: Focal hyperhidrosis: diagnosis and management. CMAJ 172: 69, 2005.
Griffin LY: Common sports injuries of the foot and ankle seen in children and adolescents. Orthop Clin North Am 25: 83, 1994.
Background: We evaluated the clinical characteristics of ingrown toenails in one of the biggest reference centers in Turkey.
Methods: This retrospective cohort study was conducted on patients admitted to Ufuk University Hospital with ingrown toenail between January 1, 2014, and December 31, 2019. Clinical characterstics and demographic features of all of the participants were evaluated, and then the study population was divided into two groups: group 1 (patients ≤20 years old) and group 2 (patients >20 years old). These groups were compared in terms of clinical findings.
Results: Disease duration, body mass index, rate of medications for chronic diseases, and rate of joint diseases were significantly higher in group 2. Rates of hyperhidrosis and sudden weight gain were significantly higher in group 1 (P < .05). Severity of ingrown toenail was significantly different between groups (P = .006). Stage 1 was the most common stage in both groups, and rate of stage 3 was higher in group 1. Onycoshisis and was more common in group 1, and nail thickening was more common in group 2 (P < .05). Nail wire and aluminum chloride were the most common treatment modalities in groups 2 and 1, respectively (P < .05). Periungual edema, presence of pus, hypertrophy, and granulation were more common in group 1 (P < .05). Thin nail plate was more common in group 1, and normal and thick nail nail plates were more common in group 2 (P < .05).
Conclusions: Clinical characteristics of ingrown toenail vary between younger and older populations. Thus, an individualized approach is preferred in the management of ingrown toenail for different age groups.